vs
Finward Bancorp（FNWD）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
Finward Bancorp的季度营收约是SUTRO BIOPHARMA, INC.的1.4倍（$16.5M vs $11.6M），Finward Bancorp同比增速更快（1.1% vs -21.4%），过去两年SUTRO BIOPHARMA, INC.的营收复合增速更高（-5.4% vs -19.1%）
Finward Bancorp是一家总部位于美国的区域性银行控股公司，主要面向本土运营区域内的个人消费者与中小企业，提供储蓄账户、各类贷款、商业融资及财富管理等零售与商业金融服务。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
FNWD vs STRO — 直观对比
营收规模更大
FNWD
是对方的1.4倍
$11.6M
营收增速更快
FNWD
高出22.4%
-21.4%
两年增速更快
STRO
近两年复合增速
-19.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.5M | $11.6M |
| 净利润 | $2.0M | — |
| 毛利率 | — | — |
| 营业利润率 | 11.0% | — |
| 净利率 | 12.0% | — |
| 营收同比 | 1.1% | -21.4% |
| 净利润同比 | -5.6% | 35.4% |
| 每股收益（稀释后） | $0.46 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FNWDSTRO
| Q4 25 | $16.5M | $11.6M | ||
| Q3 25 | $17.4M | $9.7M | ||
| Q2 25 | $16.6M | $63.7M | ||
| Q1 25 | $15.5M | $17.4M | ||
| Q4 24 | $16.3M | $14.8M | ||
| Q3 24 | $14.9M | $8.5M | ||
| Q2 24 | $14.6M | $25.7M | ||
| Q1 24 | $25.3M | $13.0M |
净利润FNWDSTRO
| Q4 25 | $2.0M | — | ||
| Q3 25 | $3.5M | $-56.9M | ||
| Q2 25 | $2.2M | $-11.5M | ||
| Q1 25 | $455.0K | $-76.0M | ||
| Q4 24 | $2.1M | $-72.4M | ||
| Q3 24 | $606.0K | $-48.8M | ||
| Q2 24 | $143.0K | $-48.0M | ||
| Q1 24 | $9.3M | $-58.2M |
营业利润率FNWDSTRO
| Q4 25 | 11.0% | — | ||
| Q3 25 | 20.5% | -499.9% | ||
| Q2 25 | 12.7% | -5.2% | ||
| Q1 25 | 4.0% | -393.8% | ||
| Q4 24 | 16.3% | -440.7% | ||
| Q3 24 | 2.7% | -797.2% | ||
| Q2 24 | 0.9% | -189.4% | ||
| Q1 24 | 40.6% | -435.0% |
净利率FNWDSTRO
| Q4 25 | 12.0% | — | ||
| Q3 25 | 20.1% | -586.6% | ||
| Q2 25 | 12.9% | -18.0% | ||
| Q1 25 | 2.9% | -436.6% | ||
| Q4 24 | 12.9% | -489.2% | ||
| Q3 24 | 4.1% | -572.6% | ||
| Q2 24 | 1.0% | -186.8% | ||
| Q1 24 | 36.7% | -447.5% |
每股收益（稀释后）FNWDSTRO
| Q4 25 | $0.46 | — | ||
| Q3 25 | $0.81 | $-0.67 | ||
| Q2 25 | $0.50 | $-0.14 | ||
| Q1 25 | $0.11 | $-0.91 | ||
| Q4 24 | $0.50 | $-27.63 | ||
| Q3 24 | $0.14 | $-0.59 | ||
| Q2 24 | $0.03 | $-0.59 | ||
| Q1 24 | $2.17 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $174.7M | $-132.5M |
| 总资产 | $2.0B | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FNWDSTRO
| Q4 25 | — | $141.4M | ||
| Q3 25 | — | $167.6M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $249.0M | ||
| Q4 24 | — | $316.9M | ||
| Q3 24 | — | $388.3M | ||
| Q2 24 | — | $375.6M | ||
| Q1 24 | — | $267.6M |
股东权益FNWDSTRO
| Q4 25 | $174.7M | $-132.5M | ||
| Q3 25 | $165.5M | $-87.3M | ||
| Q2 25 | $154.3M | $-32.1M | ||
| Q1 25 | $151.8M | $-25.8M | ||
| Q4 24 | $151.4M | $44.6M | ||
| Q3 24 | $159.6M | $111.2M | ||
| Q2 24 | $148.6M | $152.2M | ||
| Q1 24 | $151.6M | $98.0M |
总资产FNWDSTRO
| Q4 25 | $2.0B | $173.8M | ||
| Q3 25 | $2.1B | $209.7M | ||
| Q2 25 | $2.1B | $262.4M | ||
| Q1 25 | $2.0B | $321.4M | ||
| Q4 24 | $2.1B | $387.2M | ||
| Q3 24 | $2.1B | $451.8M | ||
| Q2 24 | $2.1B | $489.0M | ||
| Q1 24 | $2.1B | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $9.0M | — |
| 自由现金流率自由现金流/营收 | 54.8% | — |
| 资本支出强度资本支出/营收 | 5.2% | — |
| 现金转化率经营现金流/净利润 | 4.99× | — |
| 过去12个月自由现金流最近4个季度 | $10.6M | — |
8季度趋势，按日历期对齐
经营现金流FNWDSTRO
| Q4 25 | $9.9M | $-177.2M | ||
| Q3 25 | $1.2M | $-38.2M | ||
| Q2 25 | $4.8M | $-44.7M | ||
| Q1 25 | $-3.8M | $-67.9M | ||
| Q4 24 | $9.8M | $-71.7M | ||
| Q3 24 | $-3.7M | $-64.5M | ||
| Q2 24 | $2.8M | $9.5M | ||
| Q1 24 | $-25.0K | $-64.7M |
自由现金流FNWDSTRO
| Q4 25 | $9.0M | — | ||
| Q3 25 | $1.0M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $-4.0M | — | ||
| Q4 24 | $6.7M | — | ||
| Q3 24 | $-4.2M | — | ||
| Q2 24 | $1.1M | — | ||
| Q1 24 | $-736.0K | — |
自由现金流率FNWDSTRO
| Q4 25 | 54.8% | — | ||
| Q3 25 | 6.0% | — | ||
| Q2 25 | 27.0% | — | ||
| Q1 25 | -25.7% | — | ||
| Q4 24 | 41.2% | — | ||
| Q3 24 | -28.5% | — | ||
| Q2 24 | 7.6% | — | ||
| Q1 24 | -2.9% | — |
资本支出强度FNWDSTRO
| Q4 25 | 5.2% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 18.8% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 11.2% | — | ||
| Q1 24 | 2.8% | — |
现金转化率FNWDSTRO
| Q4 25 | 4.99× | — | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 2.22× | — | ||
| Q1 25 | -8.37× | — | ||
| Q4 24 | 4.66× | — | ||
| Q3 24 | -6.15× | — | ||
| Q2 24 | 19.23× | — | ||
| Q1 24 | -0.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
